Bristol Myers Squibb is expanding a partnership with oncology organization Sarah Cannon Research Institute, tapping into SCRI ...
The TV ad will run through Nov. 16 across major cable channels, including CNN, Fox News and ESPN, a BMS spokesperson told ...
Bristol Myers Squibb and Johnson & Johnson have stopped a phase 3 anticoagulant trial early for futility, closing off one avenue to market for a molecule tipped to generate multibillion-dollar sales.
In an era where energy efficiency and sustainability are essential, BMS have emerged as critical components in industrial and ...
BMS and J&J first linked together in 2018 to develop factor X1a inhibitors as anti-coagulants. The three Phase III Librexia ...
One of the FDA’s potential approvals this month could break an existing monopoly in the treatment space for a rare growth ...
Leonardo DRS and Thai military vehicle manufacturer Chaiseri have signed a memorandum of understanding (MOU) at the Defence & ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback